Round Comprised of New and Former Investors, Including Dr. Josef Ackermann, Wilhelm Beier, Toni Kroos, and Carsten Maschmeyer First of Two Expected Closings of Round Increases Total Capital Raised
Awakn Life Sciences Corp : Awakn Life Sciences Reports Strong Q2 2022 Results finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Awakn Life Sciences Reports Strong Q2 2022 Results streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Agreement Provides 12-Month Exclusive Period to Agree in-Licensing Deal for Proprietary Formulation of Ketamine
Toronto, Ontario (Newsfile Corp. - August 25, 2022) - Awakn Life Sciences Corp. (NEO: AWKN)